Stuart A Kingsley insider trades

Open-market stock purchases and sales by Stuart A Kingsley, Director at Indivior Pharmaceuticals, Inc, from SEC Form 4 filings since Feb 1, 2012.

Track record: 100% of 1 scored buy are up 5% or more since purchase, averaging +11%.

Recent trades

DateStockTradeValue
May 13, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—
Mar 6, 2026INDV Indivior Pharmaceuticals, IncBought$30K
Jan 26, 2026INDV Indivior Pharmaceuticals, IncBought (not open market)—

Companies traded

  • INDV Indivior Pharmaceuticals, Inc: 1 buy, last May 13, 2026
  • SRRK Scholar Rock Holding Corp: other filings, last Feb 1, 2021
  • PRTO Proteon Therapeutics Inc: other filings, last Jun 8, 2018
  • MDCO Medicines Co /DE: other filings, last Mar 1, 2017
  • BIIB Biogen Idec Inc: 7 sales, last Feb 23, 2015

Get free alerts when Stuart A Kingsley files a new trade →